Delisted
This security is no longer actively traded. Historical data is preserved for reference.No holders in 2025-Q4, no recent price data
RA PHARMACEUTICALS INC
RARX·74933V108·US·Common Stock·Unknown - Unknown
RARX (RA PHARMACEUTICALS INC) is held by 0 institutional investors as of Q2 2020.
0
Holders
Avg rating(4 Elite)
$0
Total Value
0% (72)
Fund Consensus
No signal yet — fewer than 2 funds hold RARX.
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $22.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $843,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2B | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $24.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $903,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $409,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $126,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $681,000 | 0.0% | — | 0 |
Showing 1-20 of 71
1 / 4
Continue exploring
Other Unknown stocks held by institutions
FISVFISERV INC
343 holders · $19.6B
SPYSTATE STR SPDR S&P 500 ETF T293 holders · $272.3B
IVVISHARES TR265 holders · $436.1B
IWMISHARES TR243 holders · $61.1B
VOOVANGUARD INDEX FDS243 holders · $198.5B
QQQINVESCO QQQ TR240 holders · $91.1B
GLDSPDR GOLD TR240 holders · $39B
XLFSELECT SECTOR SPDR TR223 holders · $30.1B
EFAISHARES TR222 holders · $43.9B
XLVSELECT SECTOR SPDR TR216 holders · $20.8B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer